Gene

Search results

No.	KEGG GENES	KEGG PATHWAY	KEGG DRUG	DrugBank	Disease ID
1	EDNRA	[7] Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer	D01227	Bosentan	[10] 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
2	EDNRA	[7] Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer	D07077	Ambrisentan	[7] 51, 84, 85, 86, 88, 210, 211
3	EDNRA	[7] Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer	D07538	Bosentan	[10] 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
4	EDNRB	[6] Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer	D01227	Bosentan	[10] 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
5	EDNRB	[6] Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer	D07538	Bosentan	[10] 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
6	NR3C1	[1] Neuroactive ligand-receptor interaction	D00407	Methylprednisolone	[9] 211, 220, 222, 224, 271, 283, 284, 285, 296
7	NR3C1	[1] Neuroactive ligand-receptor interaction	D05000	Methylprednisolone hemisuccinate	[1] 211
8	AR	[4] Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer	D00462	Oxandrolone	[2] 211, 285
9	PDE5A	[3] Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway	D08514	Sildenafil	[17] 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301